Related Experiment Videos
Anxiety disorders in late life: an evolving picture
E J Lenze1, K Shear, B H Mulsant
1Department of Psychology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA. lenzeej@msx.upmc.edu
CNS Spectrums
|August 30, 2003
Summary
Anxiety disorders are common in older adults, but treatment efficacy in this population needs more research. Current recommendations for selective serotonin reuptuptake inhibitors and cognitive-behavioral therapy in elderly patients require confirmation through controlled studies.
Area of Science:
- Geriatric Psychiatry
- Clinical Psychology
- Pharmacology
Background:
- Anxiety disorders are highly prevalent in older adults, impacting mortality and disability.
- Risk factors include chronic illness, disability, and limited social support.
- Limited data exists on treatment efficacy specifically in elderly populations.
Purpose of the Study:
- To review the current understanding of anxiety disorder treatments in elderly patients.
- To highlight the need for further controlled studies in this demographic.
Main Methods:
- Review of existing literature and treatment guidelines.
- Analysis of data extrapolation from younger adults and retrospective studies.
Main Results:
- Selective serotonin reuptake inhibitors and venlafaxine-extended relief are recommended first-line pharmacotherapy.
- Cognitive-behavioral therapy is recommended as first-line psychotherapy.
- Current recommendations are based on extrapolated data, not elderly-specific controlled trials.
Conclusions:
- Evidence supporting current treatment recommendations for anxiety disorders in the elderly is limited.
- Controlled studies are essential to confirm the efficacy and safety of these treatments in older adults.